Pharmena S.A. (PHR) Stock Statistics & Valuation Metrics

Pharmena S.A. has a market cap or net worth of zł34.30M. The enterprise value is zł35.24M.

Pharmena S.A. has 11,137,758 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmena S.A.’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is -32.65%.

The current PE Ratio of Pharmena S.A. is ―. Pharmena S.A.’s PEG ratio is -0.08.

In the last 12 months, Pharmena S.A. had revenue of 1.58M and earned -2.77M in profits. Earnings per share was -0.25.

In the last 12 months, operating cash flow was -3.25M and capital expenditures -364.00K, giving a free cash flow of -3.53M billion.

Pharmena S.A. pays an annual dividend of zł2.36, resulting in a dividend yield of ―

Pharmena S.A. upcoming earnings date is Sep 1, 2026, TBA (Confirmed).

Pharmena S.A. as a current ratio of 9.20, with Debt / Equity ratio of 3.71%

In the past 12 months, Pharmena S.A. has paid 25.00K in taxes.

Pharmena S.A. EV to EBITDA ratio is -9.18, with an EV/FCF ratio of -9.78.

Pharmena S.A. has zł6.79M in cash and marketable securities with zł340.00K in debt, giving a net cash position of zł6.45M billion.

Gross margin is 18.38%, with operating margin of -208.05%, and net profit margin of -175.59%.

The average price target for Pharmena S.A. is ―, which is 11.43% higher than the current price. The consensus rating is ―